BC Platforms, a leading global healthcare data technology and analytics company, announced a significant expansion of its worldwide data capabilities through a strategic partnership with GeneVault Lifesciences, a company focused on advancing diversity and equity in real-world health data. The collaboration opens access to data from 48 million patient lives and multi-modal datasets spanning over 13 countries across Asia, the Middle East, Africa, and Latin America, regions that are highly genetically diverse yet have historically been underrepresented in medical research. GeneVault continues to expand its network of data custodians, which will further increase BC Platforms’ global patient coverage over time.
Health Technology Insights: Novotech White Paper Boosts Early-Phase Oncology Strategy
This partnership gives life sciences organizations access to new patient cohorts and diverse populations where data has often been limited. GeneVault’s network currently includes more than 115 medical facilities and over 120 hospitals and medical centers that contribute clinical data and biospecimens to regional biobanks. When integrated into BC Platforms’ BC Unify data mastering platform, these datasets are harmonized and transformed into research-ready formats. The data can be accessed via trusted research environments in the cloud or through BC Platforms’ federated architecture. This integration allows for advanced analytics across the entire drug development lifecycle, from early discovery and feasibility studies to clinical trials, real-world performance monitoring, and post-market evidence generation.
Health Technology Insights: Spruce Biosciences Appoints Keli Walbert to Board
Global research initiatives have increasingly highlighted the importance of studying under-represented populations. Recent genomic studies in Latin America revealed high levels of genetic heterogeneity and complex ancestry patterns, yet these populations remain underrepresented in most genomic and real-world datasets. Similarly, genome programs in the Middle East have shown that standard reference genomes often miss critical variants, limiting the precision of medical and drug research for these populations. As regulatory authorities and payers place greater emphasis on real-world evidence to evaluate feasibility, safety, and treatment effectiveness, access to high-quality data from underrepresented populations is becoming a competitive advantage for life sciences companies. By incorporating research-ready real-world and genomic data from Asia, the Middle East, Africa, and Latin America, BC Platforms strengthens the foundation for evidence generation, clinical research, and post-market surveillance.
Mukhtar Ahmed, CEO of BC Platforms, stated that the partnership with GeneVault allows the company to provide more representative datasets to researchers, supporting the development of therapies that address the unique needs of diverse populations. He emphasized that this collaboration enhances healthcare research insights across drug discovery, clinical development, and post-launch evidence generation, while also supporting the effectiveness of precision medicine interventions. Dr. Vinod Gauba, CEO and Founder of GeneVault Lifesciences, said that the partnership represents a key step toward addressing critical gaps in global precision medicine. By linking ethically sourced real-world and genomic datasets from underrepresented populations with BC Platforms’ analytics capabilities, the collaboration enables discoveries that reflect true human diversity and accelerates the development of equitable precision therapies.
With the addition of GeneVault, BC Platforms’ global data partner network now covers over 175 million patient lives across 35 countries. This expanded network supports research across multiple therapeutic areas including oncology, immunology, neurology, cardiology, and rare diseases, giving life sciences companies access to one of the most comprehensive and diverse collections of real-world and genomic data available globally.
Health Technology Insights: Matrix One Acquires dokspot to Launch Matrix eIFU
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
